This website uses cookies to enhance the user experience.
G

GENZEB LIMITED991 023 534

Norwegian division of foreign business enterprise
Nadderudveien 138A 1359 EIKSMARKA, Norge

GENZEB LIMITED

Organization

CEO
GH

Geir Hetland1955

Chairman of the board
GH

Geir Hetland1955

Years since formation
17 years
since Mar 20, 2007
Type
Norwegian division of foreign business enterprise
VAT registered
No
Number of employees
0

Financials

Annual total result 2023
2,132,177
NOK
Total equity 2023
1,751,226
NOK
Last update: Aug 29, 2024

Management

Management / administration

NameRoleShares
GH

Geir Hetland

1955

Managing Director/CEO-

Board

NameRoleShares
GH

Geir Hetland

1955

Chairman-
G
GENZEB LIMITED
Information about the Company in the Home Country-
Last update: Apr 13, 2023

Ownership

Shares owned by the GENZEB LIMITED

NameShare classNumber of sharesShare
I
IMMUNOPHARMA AS
NO0010735335
14,466,697
10.43 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year20232022
Total operating income
0
0
Annual Total Result
2,132,177
-154,315
Total assets
1,751,226
361,282
Total liabilities
0
742,233
Total equity
1,751,226
-380,951

P&L

Year20232022
Total operating income
0
0
Total operating costs
329,665
154,315
Operating result
-329,665
-154,315
Financial income/costs
2,461,842
0
Profit before tax
2,132,177
-154,315
Total tax & extraordinary income/cost
0
0
Annual Total Result
2,132,177
-154,315

Balance overview

Year20232022
Total fixed assets
1,751,226
361,263
Total current assets
0
19
Total assets
1,751,226
361,282
Short term debt
0
742,233
Long term debt
0
0
Total liabilities
0
742,233
Contributed capital
0
0
Retained earnings
1,751,226
-380,951
Total equity
1,751,226
-380,951
Total equity and liabilities
1,751,226
361,282

Classification

Type of organization
Norwegian division of foreign business enterprise
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises